# Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis

> **NCT01998620** · PHASE4 · UNKNOWN · sponsor: **Zhejiang Hisun Pharmaceutical Co. Ltd.** · enrollment: 240 (estimated)

## Conditions studied

- Hepatitis B
- Cholestasis

## Interventions

- **DRUG:** Ademetionine 2
- **DRUG:** Ademetionine 1
- **DRUG:** Ademetionine 3

## Key facts

- **NCT ID:** NCT01998620
- **Lead sponsor:** Zhejiang Hisun Pharmaceutical Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 240 (ESTIMATED)
- **Last updated:** 2014-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01998620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01998620, "Efficacy and Safety of S-adenosyl-L-methionine in Treatment of Chronic Hepatitis B Patients With Cholestasis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01998620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*